{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:41:12Z","timestamp":1792363272066,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":193,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00478-y","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:16:22Z","timestamp":1775697382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes associated with left atrial appendage occlusion in patients with cancer-associated atrial fibrillation: a real-world propensity-matched analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Rochell","family":"Issa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Agdamag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok A.","family":"Khorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kanj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Moudgil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"478_CR1","doi-asserted-by":"publisher","unstructured":"Joglar J, Chung M, Armbruster A, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1). https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","DOI":"10.1161\/CIR.0000000000001193"},{"key":"478_CR2","doi-asserted-by":"publisher","unstructured":"Jakobsen C, Lamberts M, Carlson N, et al. Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study. BMC cancer. 2019;19(1). https:\/\/doi.org\/10.1186\/s12885-019-6314-9.","DOI":"10.1186\/s12885-019-6314-9"},{"key":"478_CR3","doi-asserted-by":"publisher","unstructured":"Falanga A, Russo L, Milesi V, Vignoli A. Mechanisms and risk factors of thrombosis in cancer. Critical reviews in oncology\/hematology. 2017;118. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.08.003.","DOI":"10.1016\/j.critrevonc.2017.08.003"},{"key":"478_CR4","doi-asserted-by":"publisher","unstructured":"Hisada Y, Mackman N. Cancer-associated pathways and biomarkers of venous thrombosis. Blood. 2017;130(13). https:\/\/doi.org\/10.1182\/blood-2017-03-743211.","DOI":"10.1182\/blood-2017-03-743211"},{"key":"478_CR5","doi-asserted-by":"publisher","unstructured":"Ikezoe T. Cancer-associated thrombosis and bleeding. International journal of hematology. 2024;119(5). https:\/\/doi.org\/10.1007\/s12185-024-03716-0.","DOI":"10.1007\/s12185-024-03716-0"},{"key":"478_CR6","doi-asserted-by":"publisher","unstructured":"Hisada Y, Geddings J, Ay C, Mackman N. Venous thrombosis and cancer: from mouse models to clinical trials. Journal of thrombosis and haemostasis : JTH. 2015;13(8). https:\/\/doi.org\/10.1111\/jth.13009.","DOI":"10.1111\/jth.13009"},{"key":"478_CR7","doi-asserted-by":"publisher","unstructured":"Streiff M, Holmstrom B, Angelini D, et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2021;19(10). https:\/\/doi.org\/10.6004\/jnccn.2021.0047.","DOI":"10.6004\/jnccn.2021.0047"},{"key":"478_CR8","doi-asserted-by":"publisher","unstructured":"Elshoury A, Schaefer J, Lim M, Skalla D, Streiff M. Update on Guidelines for the Prevention of Cancer-Associated Thrombosis. Journal of the National Comprehensive Cancer Network : JNCCN. 2022;20(13). https:\/\/doi.org\/10.6004\/jnccn.2021.7108.","DOI":"10.6004\/jnccn.2021.7108"},{"key":"478_CR9","doi-asserted-by":"publisher","unstructured":"Frere C, Font C, Esposito F, Crichi B, Girard P, Janus N. Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022;30(4). https:\/\/doi.org\/10.1007\/s00520-021-06598-8.","DOI":"10.1007\/s00520-021-06598-8"},{"key":"478_CR10","doi-asserted-by":"publisher","unstructured":"Kayano S, Santana P, Colella R, Colella M, Caruso P. Lower platelet count and metastatic tumor are associated with increased risk of spontaneous bleeding in critically ill patients with cancer: An observational study. Transfusion. 2023;63(12). https:\/\/doi.org\/10.1111\/trf.17569.","DOI":"10.1111\/trf.17569"},{"key":"478_CR11","doi-asserted-by":"publisher","unstructured":"Reddy V, Doshi S, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013;127(6). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.114389.","DOI":"10.1161\/CIRCULATIONAHA.112.114389"},{"key":"478_CR12","doi-asserted-by":"publisher","unstructured":"Pollick C, Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation. 1991;84(1). https:\/\/doi.org\/10.1161\/01.cir.84.1.223.","DOI":"10.1161\/01.cir.84.1.223"},{"key":"478_CR13","doi-asserted-by":"publisher","unstructured":"Anic A, Bakovic D, Jurisic Z, et al. Diagnostic and therapeutic pathways for the malignant left atrial appendage: European Heart Rhythm Association physician survey. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2023;25(7). https:\/\/doi.org\/10.1093\/europace\/euad204.","DOI":"10.1093\/europace\/euad204"},{"key":"478_CR14","doi-asserted-by":"publisher","unstructured":"Kumar S, Yoon S, Milioglou I, et al. Left Atrial Appendage Closure Outcomes in Patients With Cancer at a Single Tertiary Center. The American journal of cardiology. 2023;202. https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.068.","DOI":"10.1016\/j.amjcard.2023.06.068"},{"key":"478_CR15","doi-asserted-by":"publisher","unstructured":"von Elm E, Altman D, Egger M, Pocock S, G\u00f8tzsche P, Vandenbroucke J. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Journal of clinical epidemiology. 2008;61(4). https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"478_CR16","doi-asserted-by":"publisher","unstructured":"Bergmark B, Kamphuisen P, Wiviott S, et al. Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial. Circulation. 2019;140(22). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041346.","DOI":"10.1161\/CIRCULATIONAHA.119.041346"},{"key":"478_CR17","doi-asserted-by":"publisher","unstructured":"Tinoco M, Echarte-Morales J, Guerreiro C, et al. Short- and long-term outcomes of percutaneous left atrial appendage occlusion in cancer patients. International journal of cardiology Heart & vasculature. 2024;56. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101585.","DOI":"10.1016\/j.ijcha.2024.101585"},{"key":"478_CR18","doi-asserted-by":"publisher","unstructured":"Zweiker D, Bergler-Klein J, Fiedler L, et al. Left Atrial Appendage Closure in Atrial Fibrillation Patients with Cancer. Journal of clinical medicine. 2024;13(21). https:\/\/doi.org\/10.3390\/jcm13216514.","DOI":"10.3390\/jcm13216514"},{"key":"478_CR19","doi-asserted-by":"publisher","unstructured":"Moik F, Makatsariya A, Ay C. Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management. Thrombosis research. 2021;199. https:\/\/doi.org\/10.1016\/j.thromres.2020.12.016.","DOI":"10.1016\/j.thromres.2020.12.016"},{"key":"478_CR20","doi-asserted-by":"publisher","unstructured":"Patel H, Khorana A. Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid. Current oncology reports. 2019;21(2). https:\/\/doi.org\/10.1007\/s11912-019-0767-5.","DOI":"10.1007\/s11912-019-0767-5"},{"key":"478_CR21","doi-asserted-by":"publisher","unstructured":"Bellesoeur A, Thomas-Schoemann A, Allard M, et al. Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences. Critical reviews in oncology\/hematology. 2018;129. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.06.015.","DOI":"10.1016\/j.critrevonc.2018.06.015"},{"key":"478_CR22","doi-asserted-by":"publisher","unstructured":"Bolek H, \u00dcr\u00fcn Y. Cancer-associated thrombosis and drug-drug interactions of antithrombotic and antineoplastic agents. Cancer. 2023;129(20). https:\/\/doi.org\/10.1002\/cncr.34937.","DOI":"10.1002\/cncr.34937"},{"key":"478_CR23","doi-asserted-by":"publisher","unstructured":"Angelini D, Radivoyevitch T, McCrae K, Khorana A. Bleeding incidence and risk factors among cancer patients treated with anticoagulation. American journal of hematology. 2019;94(7). https:\/\/doi.org\/10.1002\/ajh.25494.","DOI":"10.1002\/ajh.25494"},{"key":"478_CR24","doi-asserted-by":"publisher","unstructured":"Pastori D, Marang A, Bisson A, et al. Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study. Cancer. 2021;127(12):2122\u20132129. https:\/\/doi.org\/10.1002\/cncr.33470.","DOI":"10.1002\/cncr.33470"},{"key":"478_CR25","doi-asserted-by":"publisher","unstructured":"Osmancik P, Herman D, Neuzil P. Investigators obotP-T. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation. JACC. 2022 79(1):1\u201314. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.023.","DOI":"10.1016\/j.jacc.2021.10.023"},{"key":"478_CR26","doi-asserted-by":"publisher","unstructured":"Holmes D, Kar S, Price M, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. Journal of the American College of Cardiology. 2014;64(1). https:\/\/doi.org\/10.1016\/j.jacc.2014.04.029.","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"478_CR27","doi-asserted-by":"publisher","unstructured":"Branny M, Osmancik P, Kala P, et al. Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trial. Journal of cardiovascular electrophysiology. 2023;34(9). https:\/\/doi.org\/10.1111\/jce.16029.","DOI":"10.1111\/jce.16029"},{"key":"478_CR28","doi-asserted-by":"publisher","unstructured":"Wazni O, Saliba W, Nair D, et al. Left Atrial Appendage Closure after Ablation for Atrial Fibrillation. The New England journal of medicine. 2025;392(13). https:\/\/doi.org\/10.1056\/NEJMoa2408308.","DOI":"10.1056\/NEJMoa2408308"},{"key":"478_CR29","doi-asserted-by":"publisher","unstructured":"Jiang H, Koh T, Vengkat V, et al. An Updated Meta-Analysis on the Clinical Outcomes of Percutaneous Left Atrial Appendage Closure Versus Direct Oral Anticoagulation in Patients With Atrial Fibrillation. The American journal of cardiology. 2023;200. https:\/\/doi.org\/10.1016\/j.amjcard.2023.05.044.","DOI":"10.1016\/j.amjcard.2023.05.044"},{"key":"478_CR30","doi-asserted-by":"publisher","unstructured":"Osmancik P, Herman D, Neuzil P, et al. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 2020;75(25). https:\/\/doi.org\/10.1016\/j.jacc.2020.04.067.","DOI":"10.1016\/j.jacc.2020.04.067"},{"key":"478_CR31","doi-asserted-by":"publisher","unstructured":"Darden D, Bilal Munir M, Zimmerman S, Eskander M, Pothineni NVK, Gopinathannair R, et al. Correction: Frailty and associated outcomes in patients undergoing percutaneous left atrial appendage occlusion: findings from the NCDR LAAO registry. J Interv Card Electrophysiol. 2024;67(3):637. https:\/\/doi.org\/10.1007\/s10840-023-01704-8.","DOI":"10.1007\/s10840-023-01704-8"},{"key":"478_CR32","doi-asserted-by":"publisher","unstructured":"Aarnink EW, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, et al. Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial. Europace. 2024;26(7):euae188. https:\/\/doi.org\/10.1093\/europace\/euae188.","DOI":"10.1093\/europace\/euae188"},{"key":"478_CR33","doi-asserted-by":"publisher","unstructured":"Magnocavallo M, Della Rocca D, Vetta G, et al. Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score-matched comparison with direct oral anticoagulant. Heart rhythm. 2024;21(8). https:\/\/doi.org\/10.1016\/j.hrthm.2024.01.018.","DOI":"10.1016\/j.hrthm.2024.01.018"},{"key":"478_CR34","doi-asserted-by":"publisher","unstructured":"Oliva A, Ioppolo A, Chiarito M, et al. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis. Journal of the American Heart Association. 2024;13(16). https:\/\/doi.org\/10.1161\/JAHA.124.034815.","DOI":"10.1161\/JAHA.124.034815"},{"key":"478_CR35","doi-asserted-by":"publisher","unstructured":"Branny M, Osmancik P, Kala P, Poloczek M, Herman D, Neuzil P, et. al. PRAGUE-17 Trial Investigators. Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trial. J Cardiovasc Electrophysiol. 2023 Sep;34(9):1885-1895. https:\/\/doi.org\/10.1111\/jce.16029. Epub 2023 Aug 2. PMID: 37529864.","DOI":"10.1111\/jce.16029"},{"key":"478_CR36","doi-asserted-by":"publisher","unstructured":"Nielsen-Kudsk J, Korsholm K, Damgaard D, et al. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation. JACC Cardiovascular interventions. 2021;14(1). https:\/\/doi.org\/10.1016\/j.jcin.2020.09.051.","DOI":"10.1016\/j.jcin.2020.09.051"},{"key":"478_CR37","doi-asserted-by":"publisher","unstructured":"Alkhouli M, Di Biase L, Natale A, et al. Nonthrombogenic Roles of the Left Atrial Appendage: JACC Review Topic of the Week. JACC. 2023;81(11):1063\u20131075. https:\/\/doi.org\/10.1016\/j.jacc.2023.01.017.","DOI":"10.1016\/j.jacc.2023.01.017"},{"key":"478_CR38","doi-asserted-by":"publisher","unstructured":"D L, Turagam M, Afzal M, et al. Left Atrial Appendage Closure and Systemic Homeostasis: The LAA HOMEOSTASIS Study. Journal of the American College of Cardiology. 2018;71(2). https:\/\/doi.org\/10.1016\/j.jacc.2017.10.092.","DOI":"10.1016\/j.jacc.2017.10.092"},{"key":"478_CR39","doi-asserted-by":"publisher","unstructured":"Lakkireddy D, Wilber D, Mittal S, et al. Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial. JAMA. 2024;331(13). https:\/\/doi.org\/10.1001\/jama.2024.3026.","DOI":"10.1001\/jama.2024.3026"},{"key":"478_CR40","doi-asserted-by":"publisher","unstructured":"Kupczynska K, Michalski B, Miskowiec D, et al. Association between left atrial function assessed by speckle-tracking echocardiography and the presence of left atrial appendage thrombus in patients with atrial fibrillation. Anatolian journal of cardiology. 2017;18(1). https:\/\/doi.org\/10.14744\/AnatolJCardiol.2017.7613.","DOI":"10.14744\/AnatolJCardiol.2017.7613"},{"key":"478_CR41","doi-asserted-by":"publisher","unstructured":"Liu J, Barac A, Thavendiranathan P, Scherrer-Crosbie M. Strain Imaging in Cardio-Oncology. JACC CardioOncology. 2020;2(5). https:\/\/doi.org\/10.1016\/j.jaccao.2020.10.011.","DOI":"10.1016\/j.jaccao.2020.10.011"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00478-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00478-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00478-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:21:53Z","timestamp":1792362113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00478-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00478-y","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Ethical review and approval were waived for this study because the analysis used deidentified data from the TriNetX Research Network. Individual institutional review board approval was not required, as no identifiable patient information was accessed or analyzed.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was waived because only deidentified electronic health records were used for analysis, and no direct patient contact or identifiable information was involved.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"129"}}